KCT0006013
Completed
N/A
A Clinical Study Evaluating the Safety and Effectiveness of the Ultrasound-guided Modified Thread Carpal Tunnel Release with Smartwire®; Pilot Study
The Catholic University of Korea, Incheon St. Mary's Hospital0 sites15 target enrollmentTBD
ConditionsDiseases of the nervous system
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Diseases of the nervous system
- Sponsor
- The Catholic University of Korea, Incheon St. Mary's Hospital
- Enrollment
- 15
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Those from 20 to 75 years old
- •\- Those diagnosed with carpal tunnel syndrome by clinical symptoms, electromyography, and ultrasonography
- •\- Those who did not respond to conservative treatment (physical therapy, drug therapy, injection therapy) for carpal tunnel syndrome or showed insufficient effect
Exclusion Criteria
- •\-Those with a history of having previously undergone resection of the transverse carpal ligament
- •\-Those who have other causes for the symptoms of carpal tunnel syndrome on the ultrasound examination (e.g. cysts, tumors, etc.)
- •\-Those with cognitive disorders that make it difficult to assess the degree of pain
- •\-Those unable to cooperate in evaluation, treatment and follow\-up observation
- •\-Pregnancy and lactating women
- •\-Those who take anticoagulants
- •\-Those who are judged to be inadequate for conducting clinical trials as judged by other investigators
- •\-Those who have participated in other clinical trials within 3 months prior to the implementation of this clinical trial
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
Phase 4
To study the effect of Panchakarma Essential (Nirgundi-based formulation) in Knee Osteoarthritis.CTRI/2023/07/055689Mprex Healthcare Pvt. Ltd.
Active, Not Recruiting
Phase 1
A clinical study to evaluate the safety and effectiveness of NOVOCART® 3D plus compared to the standard of care (microfracture) in the treatment of cartilage defects of the knee.EUCTR2011-005798-22-DETETEC – Tissue Engineering Technologies – AG261
Active, Not Recruiting
Phase 1
A clinical study to evaluate the safety and effectiveness of NOVOCART® 3D plus compared to the standard of care (microfracture) in the treatment of cartilage defects of the knee.EUCTR2011-005798-22-LVTETEC – Tissue Engineering Technologies – AG261
Active, Not Recruiting
Phase 1
A clinical study to evaluate the safety and effectiveness of NOVOCART® 3D plus compared to the standard of care (microfracture) in the treatment of cartilage defects of the knee.Repair of localized, full-thickness cartilage defects of the femoral condyle (medial, lateral or trochlea) of 2-6cm².MedDRA version: 20.0Level: PTClassification code 10052913Term: Cartilage operationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 21.1Level: LLTClassification code 10007705Term: Cartilage damageSystem Organ Class: 100000004863MedDRA version: 20.0Level: LLTClassification code 10057104Term: Cartilage repairSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 20.0Level: PTClassification code 10064112Term: Cartilage graftSystem Organ Class: 10042613 - Surgical and medical proceduresTherapeutic area: Body processes [G] - Cell Physiological Phenomena [G04]EUCTR2011-005798-22-LTTETEC – Tissue Engineering Technologies – AG261
Withdrawn
Phase 3
A Clinical Study to Evaluate the Safety and Effectiveness of NOVOCART® 3D plus Compared to Microfracture in the Treatment of Articular Cartilage Defects of the KneeNL-OMON40824TETEC AG30